Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?

Detalhes bibliográficos
Autor(a) principal: Monteiro,P.
Data de Publicação: 2012
Outros Autores: Miranda-Filho,D.B., Bandeira,F., Lacerda,H.R., Chaves,H., Albuquerque,M.F.P.M., Montarroyos,U.R., Ximenes,R.A.A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000900005
Resumo: We investigated the association between pulse wave velocity (PWV) and HIV infection, antiretroviral treatment-related characteristics, viral load, immune status, and metabolic changes in a cross-sectional study nested in a cohort of HIV/AIDS patients who have been followed for metabolic and cardiovascular changes since 2007. The study included patients recruited from the cohort (N = 261) and a comparison group (N = 82) of uninfected individuals, all enrolled from April to November 2009. Aortic stiffness was estimated using the carotid-femoral PWV (Complior-Artech, Paris, France). The groups were similar with respect to age, metabolic syndrome, diabetes mellitus, Framingham score, and use of antihypertensive and hypolipidemic medications. Hypertension was more frequent among the controls. Individuals with HIV had higher triglyceride, glucose and HDL cholesterol levels. Among individuals with HIV/AIDS, those with a nadir CD4+ T-cell count <200 cells/mm³ had a higher PWV (P = 0.01). There was no statistically significant difference when subjects were stratified by gender. Heart rate, age, male gender, and blood pressure were independently correlated with PWV. Nadir CD4+ T-cell count did not remain in the final model. There was no significance difference in PWV between HIV-infected individuals and uninfected controls. PWV was correlated with age, gender, and blood pressure across the entire population and among those infected with HIV. We recommend cohort studies to further explore the association between inflammation related to HIV infection and/or immune reconstitution and antiretroviral use and PWV.
id ABDC-1_eb14907747da7b5ebfc6b22d1c383955
oai_identifier_str oai:scielo:S0100-879X2012000900005
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?HIVAIDSAntiretroviral therapyArterial stiffnessPulse wave velocityWe investigated the association between pulse wave velocity (PWV) and HIV infection, antiretroviral treatment-related characteristics, viral load, immune status, and metabolic changes in a cross-sectional study nested in a cohort of HIV/AIDS patients who have been followed for metabolic and cardiovascular changes since 2007. The study included patients recruited from the cohort (N = 261) and a comparison group (N = 82) of uninfected individuals, all enrolled from April to November 2009. Aortic stiffness was estimated using the carotid-femoral PWV (Complior-Artech, Paris, France). The groups were similar with respect to age, metabolic syndrome, diabetes mellitus, Framingham score, and use of antihypertensive and hypolipidemic medications. Hypertension was more frequent among the controls. Individuals with HIV had higher triglyceride, glucose and HDL cholesterol levels. Among individuals with HIV/AIDS, those with a nadir CD4+ T-cell count <200 cells/mm³ had a higher PWV (P = 0.01). There was no statistically significant difference when subjects were stratified by gender. Heart rate, age, male gender, and blood pressure were independently correlated with PWV. Nadir CD4+ T-cell count did not remain in the final model. There was no significance difference in PWV between HIV-infected individuals and uninfected controls. PWV was correlated with age, gender, and blood pressure across the entire population and among those infected with HIV. We recommend cohort studies to further explore the association between inflammation related to HIV infection and/or immune reconstitution and antiretroviral use and PWV.Associação Brasileira de Divulgação Científica2012-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000900005Brazilian Journal of Medical and Biological Research v.45 n.9 2012reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/S0100-879X2012007500116info:eu-repo/semantics/openAccessMonteiro,P.Miranda-Filho,D.B.Bandeira,F.Lacerda,H.R.Chaves,H.Albuquerque,M.F.P.M.Montarroyos,U.R.Ximenes,R.A.A.eng2012-08-16T00:00:00Zoai:scielo:S0100-879X2012000900005Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2012-08-16T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?
title Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?
spellingShingle Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?
Monteiro,P.
HIV
AIDS
Antiretroviral therapy
Arterial stiffness
Pulse wave velocity
title_short Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?
title_full Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?
title_fullStr Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?
title_full_unstemmed Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?
title_sort Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?
author Monteiro,P.
author_facet Monteiro,P.
Miranda-Filho,D.B.
Bandeira,F.
Lacerda,H.R.
Chaves,H.
Albuquerque,M.F.P.M.
Montarroyos,U.R.
Ximenes,R.A.A.
author_role author
author2 Miranda-Filho,D.B.
Bandeira,F.
Lacerda,H.R.
Chaves,H.
Albuquerque,M.F.P.M.
Montarroyos,U.R.
Ximenes,R.A.A.
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Monteiro,P.
Miranda-Filho,D.B.
Bandeira,F.
Lacerda,H.R.
Chaves,H.
Albuquerque,M.F.P.M.
Montarroyos,U.R.
Ximenes,R.A.A.
dc.subject.por.fl_str_mv HIV
AIDS
Antiretroviral therapy
Arterial stiffness
Pulse wave velocity
topic HIV
AIDS
Antiretroviral therapy
Arterial stiffness
Pulse wave velocity
description We investigated the association between pulse wave velocity (PWV) and HIV infection, antiretroviral treatment-related characteristics, viral load, immune status, and metabolic changes in a cross-sectional study nested in a cohort of HIV/AIDS patients who have been followed for metabolic and cardiovascular changes since 2007. The study included patients recruited from the cohort (N = 261) and a comparison group (N = 82) of uninfected individuals, all enrolled from April to November 2009. Aortic stiffness was estimated using the carotid-femoral PWV (Complior-Artech, Paris, France). The groups were similar with respect to age, metabolic syndrome, diabetes mellitus, Framingham score, and use of antihypertensive and hypolipidemic medications. Hypertension was more frequent among the controls. Individuals with HIV had higher triglyceride, glucose and HDL cholesterol levels. Among individuals with HIV/AIDS, those with a nadir CD4+ T-cell count <200 cells/mm³ had a higher PWV (P = 0.01). There was no statistically significant difference when subjects were stratified by gender. Heart rate, age, male gender, and blood pressure were independently correlated with PWV. Nadir CD4+ T-cell count did not remain in the final model. There was no significance difference in PWV between HIV-infected individuals and uninfected controls. PWV was correlated with age, gender, and blood pressure across the entire population and among those infected with HIV. We recommend cohort studies to further explore the association between inflammation related to HIV infection and/or immune reconstitution and antiretroviral use and PWV.
publishDate 2012
dc.date.none.fl_str_mv 2012-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000900005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000900005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0100-879X2012007500116
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.45 n.9 2012
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302941627416576